A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
about
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3Real-time visualization and quantitation of vascular permeability in vivo: implications for drug deliveryThe crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolutionVascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouchImmunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic.VEGF antagonists.Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Perlecan and tumor angiogenesis.Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomasNovel vascular endothelial growth factor D variants with increased biological activityTargeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors.Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeabilityThe 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2.A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors.Viral vascular endothelial growth factor plays a critical role in orf virus infection.Intercellular adhesion molecule-1 and blood-spinal cord barrier disruption in central nervous system radiation injury.Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization.A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor.MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance.Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.A Novel Splice-Site Mutation in Is Associated with Congenital Primary Lymphoedema of GordonThe C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1
P2860
Q24291630-27B346F6-B085-4FC0-BA54-C45F4C988E01Q27306235-D9C38991-1909-4707-84A6-DB68418BA182Q27628017-1FB4DC9A-06AB-4CD7-AB8A-BA5413EC3C40Q28360225-1F9E9F4D-BC74-4E3F-8FEC-51FDA0CEA9FFQ30715508-02A8C9F5-EC9A-4E64-A2C3-16A8CF9CEC89Q34319721-6EB7E272-671B-43FC-B8B8-F0704362ED07Q34451927-6C6C4A6B-8521-4C68-8889-E9C3EF532DE2Q35049227-FC1F0973-FDFA-4962-835A-39D13E528DC0Q35562693-2FBE03AC-B54D-452B-9CAF-D7E827937383Q35836386-3FE1914B-ABC8-4010-8CF4-D28E4C531A51Q37257420-9E52E0A7-0C23-4583-8CBE-BCF82FF2C910Q37398065-A44ABC61-A8DB-4E21-980C-525C8C04CA38Q37413669-58C15832-978B-4388-888C-26663CE8FD4FQ37986496-BAC48EC3-37FB-4201-86C4-629B2D8E58FDQ38187496-085FF76A-0508-4A17-BB35-4C1426CC509AQ38301216-0C214F1C-D61F-4D98-AB93-92F359001FFDQ38749030-4E2E83D9-A046-4FDD-807D-89ECDB698BE4Q38782636-3CF9D9E4-E823-446A-9843-887B55D0E130Q39585494-D70DDCD8-131A-40BB-89A3-4A6FBB996667Q39687446-0E968B18-39B9-4DB6-B62C-0707FEE43780Q39714957-C86B2A6D-BBE9-4242-9DF0-FC9FD909712CQ39819854-2EFAD0D4-68FE-4B92-B511-93F8BEFB0005Q40169031-5DC72F99-FB11-472B-8B03-428C535169F7Q40705863-235A1985-A9E7-481B-95E5-62E413144654Q41744785-742D50D4-1938-4351-B5C8-DB088C1FB687Q42049137-467B145A-8E55-40CB-B346-542BF1CC3915Q42292864-2D32293B-17F4-415B-9025-7FB21B1CA4A7Q42826185-B870AD9C-4CBD-4DDC-A4D9-C223BE0E0EC7Q43509136-0DE26610-C43D-4F08-B394-00F7F3743552Q43580820-599C928F-B1DB-476F-A9A7-E32336B4127BQ51367380-4D8BFFC4-4911-4AE9-8605-F9593336123AQ54495902-2DF0E390-FD1F-4E02-BA2F-CA838443FED4Q55472739-EE882033-89D6-40D4-8836-EE0C17555D30Q57150749-0A6E6712-FFC8-43D4-990D-37CA8D25DA60Q58045402-04E61B41-2C41-4AB2-ABED-B315094B41D8
P2860
A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A mutant form of vascular endo ...... induce vascular permeability.
@en
A mutant form of vascular endothelial growth factor
@nl
type
label
A mutant form of vascular endo ...... induce vascular permeability.
@en
A mutant form of vascular endothelial growth factor
@nl
prefLabel
A mutant form of vascular endo ...... induce vascular permeability.
@en
A mutant form of vascular endothelial growth factor
@nl
P2093
P2860
P356
P1476
A mutant form of vascular endo ...... induce vascular permeability.
@en
P2093
Domagala T
Groenen LC
Stacker SA
P2860
P304
34884-34892
P356
10.1074/JBC.274.49.34884
P407
P577
1999-12-01T00:00:00Z